Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Krishana Phoschem Ltd
| Q3 FY26 Earnings Conference Call
Summary : Krishana Phoschem achieved record Q3 FY26 results, driven by capacity expansion and strong demand, with a positive outlook for future growth.
Management Perspective positive : Management repeatedly highlighted 'record-breaking quarterly performance,' 'highest ever PAT,' 'all-time high EPS,' and a 'robust outlook' for the future.
Concall Report Analysis & Insights
Business Overview
- Achieved record-breaking Q3 FY26 performance.
- Driven by new strategic initiatives and expanded capacity utilization.
- Leveraged enhanced operating efficiencies and robust distribution network.
- Benefited from favorable agricultural landscape and government policies.
- Capitalizing on industry shift from DAP to balanced NPK/SSP blends.
Future Growth Prospects
- 50% NPK/DAP capacity expansion at Meghnagar commissioning by March 2026.
- New plant expected to add Rs. 1,000 crores in revenue potential.
- Targeting 60% capacity utilization for the new plant in its first year.
- Actively evaluating new strategic opportunities to diversify portfolio.
- Outlook remains robust due to favorable macro-agricultural tailwinds.
Management Insights
- Pleased with record-breaking quarterly performance in Q3 FY26.
- Expanded in-house capacity utilization beyond core functions.
- Successfully leveraged enhanced operating efficiencies for growth.
- Outlook remains robust, anchored by favorable macro-agricultural tailwinds.
- Committed to maintaining 14-15% EBITDA margin for manufactured products.
Signs of Skepticism
- Profitability from imports is very low, impacting overall margins.
- High corporate tax rate of around 40% due to Minimum Alternate Tax (MAT).
- Reliance on imports to meet demand for certain NPK variants.
Risk Factors
- Operating in a competitive market environment.
- Dependence on government subsidies for fertilizer affordability.
- Raw material cost increases, specifically sulfur and sulfuric acid.
- Profitability in imported products is very low.
- Logistics issues can impact manufacturing turnover and dispatches.
Good To Know
- Total Rabi crop coverage increased by 7 lakh hectares over previous year.
- Reservoir storage levels are higher than last year, supporting irrigation.
- Government approved new Nutrient Based Subsidy (NBS) rates for Rabi 2025-26.
- Mission for Aatmanirbharta in Pulses launched with 11,440 crore budget.
- Government enforcement actions curb fertilizer diversion and hoarding.
Key Drivers
- New plant commissioning by March.
- Increased NPK/DAP production capacity.
- Strong fertilizer demand visibility.
- Government subsidy support continues.
Key Analyst Discussions
Competitive Environment
- Q: How is the inventory situation for DAP for Rabi and Kharif seasons?
- A: DAP usage is declining globally; NPK variants are increasingly preferred.
- A: Domestic phosphatic fertilizer supply is less than demand, requiring imports.
- Q: Can you provide an overview of industry seasonality and peak demand?
- A: Covered in opening remarks, focusing on industry functions and demand shifts.
Market Trends & Consumer Behavior
- Q: How do farmer preferences impact DAP versus NPK sales?
- A: Farmers prefer NPK variants tailored to soil/crop needs over generic DAP.
- A: Different NPK variants ensure higher crop productivity for farmers.
Financial Highlights
- Q: How will EBITDA per ton for NPK pan out for Q4 and Kharif season?
- A: Company aims to maintain 14-15% EBITDA margin for manufactured products.
- Q: What was the proportion of trading revenue for Q3?
- A: Rs. 245 crores from imports, Rs. 413 crores from manufacturing.
- Q: What is the revenue target for the entire FY26?
- A: Revenue will exceed the nine-month average of Rs. 570 crores per quarter.
Product Composition
- Q: Does the new plant add new NPK variants?
- A: Capacity exists, but current single variant demand is unmet.
- A: Imports are used to supply other NPK variants to farmers.
Strategic Considerations
- Q: Update on DAP, NPK, and Sulfuric acid expansion at Meghnagar?
- A: Commissioning by March 2026, commercial production by April.
- Q: What are the expansion plans beyond March '26 and funding?
- A: No immediate plans, will explore possibilities using cash accruals.
- Q: Any plan for listing the Company on BSE?
- A: Not discussed at Board level, but will examine the possibility.
- Q: Why is the corporate tax rate high at 40%?
- A: Due to MAT, company falls under 30% tax slab plus surcharge/cess.